Two Sigma Investments, LP Revelation Biosciences, Inc. Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.09 - $1438.5 $1,627 - $26 Million
18,081 New
18,081 $5,000
Q2 2022

Aug 15, 2022
SELL
$448.98 - $1344.0 $14.6 Million - $43.7 Million
-32,540 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$971.04 - $11077.5 $31.6 Million - $360 Million
32,540 New
32,540 $37,000

Others Institutions Holding REVB

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About REVELATION BIOSCIENCES, INC.

REVB Quotes by TradingView
  • Ticker REVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,525,800
  • Market Cap $17.9M
  • Description
  • Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99b that is in a Phase Ib clinical trial for the prevention or treatment of chronic nasal conge...
More about REVB
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email